Related Experiment Video
Updated: Aug 7, 2026
05:53
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Frail elderly, nutritional status and drugs
1INSERM EMI 9904, Unité de Pharmacologie Clinique, Bâtiment 3C, Centre Hospitalier Universitaire, 58 rue Montalembert BP 321, F-63009 Clermont-Ferrand, France. gisele.pickering@u-clermont1.fr
Archives of Gerontology and Geriatrics
|December 31, 2003
Summary
Nutritional status significantly impacts how frail elderly individuals respond to medications. Both diet and drugs can negatively affect elderly nutrition, highlighting a need for more research on these critical interactions.
Area of Science:
- Gerontology
- Clinical Pharmacology
- Nutritional Science
Background:
- Frail elderly individuals often experience impaired nutritional status.
- Nutritional status influences drug pharmacology due to physiological changes.
- The interplay between nutrition and medication is crucial in geriatric care.
Purpose of the Study:
- To review the complex interactions between nutritional status and drug effects in frail elderly persons.
- To highlight the bidirectional relationship where nutrition affects drug action and drugs impact nutritional state.
- To identify gaps in current research regarding these interactions.
Main Methods:
- Literature review focusing on studies examining nutrition-drug interactions in the elderly.
- Analysis of physiological mechanisms linking nutritional status to drug pharmacokinetics and pharmacodynamics.
- Synthesis of evidence on the direct and indirect effects of drugs on elderly nutrition.
Main Results:
- Impaired nutritional status in the frail elderly significantly alters drug pharmacology.
- Food intake plays a central role in drug interactions.
- Drugs can adversely affect the nutritional status of elderly patients.
Conclusions:
- There is a significant, yet under-researched, interaction between nutritional status and drug efficacy/toxicity in frail elderly individuals.
- Further clinical studies with adequate representation of frail elderly are essential.
- Understanding these interactions is vital for optimizing pharmacotherapy and nutritional support in this population.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...